Characterization of Bovine Adrenal Medulla (BAM8-22) as a New Surrogate Model of Non-histaminergic Itch
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- itch rating
研究概览
简要总结
With this experiment, the experimenter wish evaluate the role of TRPA1 on non-histaminergic itch induced by BAM8-22
详细描述
With this experiment, the experimenter wish evaluate the role of TRPA1 on non-histaminergic itch induced by BAM8-22 2 (Bovine Adrenal Medulla), which is found naturally in the human body and which has proved to evoke itch. To evaluate the role of TRPA1 it will be used a TRPA1 antagonist (A-967079)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Sequential
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy men and women
- •18-60 years
- •Speak and understand English
排除标准
- •Pregnancy or lactation
- •Drug addiction defined as any use of cannabis, opioids or other drugs
- •Previous or current history of neurological, dermatological, immunological musculoskeletal, cardiac disorder or mental illnesses that may affect the results (e.g. neuropathy, muscular pain in the upper extremities, etc.)
- •Moles, wounds, scars or tattoos in the area to be treated or tested
- •Lack of ability to cooperate •
- •Current use of medications that may affect the trial such as antihistamines and pain killers.
- •Skin diseases
- •Consumption of alcohol or painkillers 24 hours before the study days and between these - Acute or chronic pain •
- •Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical trials)
研究组 & 干预措施
A-967079 Injections + BAM8-22
干预措施: A-967079 and BAM8-22 application (Drug)
A-967079 Injections + BAM8-22
干预措施: A-967079 and BAM8-22 application after 5 minutes. (Drug)
A-967079 Injections and vehicle
干预措施: A-967079 application. (Drug)
A-967079 Injections and vehicle
干预措施: Vehicle and BAM8-22 application. (Drug)
结局指标
主要结局
itch rating
时间窗: change from baseline, up to 10 minutes after the application
the subject will rate the itch for 10 minutes by using a visual analog scale (VAS) on a tablet. this scale goes from 0 to 100. 0 indicates "no itch" and 100 indicates "worst imaginable itch"
Pain supra-threshold heat Stimuli
时间窗: change from baseline, up to 10 minutes after the application
the tests for thermal sensation will all be performed using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device
Alloknesis
时间窗: change from baseline, up to 10 minutes after the application
s measured by using a mildy pruritic, non-painful von Frey filaments of a predetermined intensity (generally 5-30 milliNewton of force)
mechanical pain threshold and sensitivity
时间窗: change from baseline, up to 10 minutes after the application
is performed using a pin-prick set (Aalborg University). The set consists of 8 needles each having a diameter of 0,6 mm and different force applications
superficial blood perfusion
时间窗: change from baseline, up to 10 minutes after the application
is measured by a speckle contrast imager (FLPI, Moor Instruments, England)
Warm Detection Threshold, and Heat Pain threshold
时间窗: change from baseline, up to 10 minutes after the application
he tests for thermal sensation will all be performed using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device
Cold Detection Threshold and Cold Pain threshold
时间窗: change from baseline, up to 10 minutes after the application
the tests for thermal sensation will all be performed using a PATHWAY ATS (Medoc Ltd, Israel) thermal sensory testing device
次要结局
- pain rating(change from baseline, up to 10 minutes after the application)
研究者
Giulia Erica Aliotta
Principal Investigator, PhD fellow
Aalborg University